Remdesivir Shows Promise in Trials

April 28, 2020

Remdesivir Shows Promise in Trials

Gilead Sciences’ antiviral medicine remdesivir has demonstrated promising results in clinical trials for patients with severe complications from COVID-19. As a premium courier, Yourway transports crucial clinical trial materials across our extensive network.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?